Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), announced today its key "Alnylam 5x15™" pipeline and partner program goals for 2013 through 2014.
This article: 1796 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE